Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies

Simple item page

Simple item page

Full item details

creativework.keywords - en
COVID-19 (Disease)--Diagnosis
Biosensors
Biocapteurs
creativework.keywords - fr
Diagnostics biologiques délocalisés
Point-of-care testing
Réaction immunitaire
Immune response
dc.contributor.author
Shoute, Lian C. T.
Abdelrasoul, Gaser N.
Ma, Yuhao
Duarte, Pedro A.
Edwards, Cole
Zhuo, Ran
Zeng, Jie
Feng, Yiwei
Charlton, Carmen L.
Kanji, Jamil N.
Babiuk, Shawn
Chen, Jie
dc.date.accepted
2022-09-25
dc.date.accessioned
2024-08-16T18:12:48Z
dc.date.available
2024-08-16T18:12:48Z
dc.date.issued
2023-01-01
dc.date.submitted
2022-04-15
dc.description.abstract - en
The COVID-19 pandemic has posed enormous challenges for existing diagnostic tools to detect and monitor pathogens. Therefore, there is a need to develop point-of-care (POC) devices to perform fast, accurate, and accessible diagnostic methods to detect infections and monitor immune responses. Devices most amenable to miniaturization and suitable for POC applications are biosensors based on electrochemical detection. We have developed an impedimetric immunosensor based on an interdigitated microelectrode array (IMA) to detect and monitor SARS-CoV-2 antibodies in human serum. Conjugation chemistry was applied to functionalize and covalently immobilize the spike protein (S-protein) of SARS-CoV-2 on the surface of the IMA to serve as the recognition layer and specifically bind anti-spike antibodies. Antibodies bound to the S-proteins in the recognition layer result in an increase in capacitance and a consequent change in the impedance of the system. The impedimetric immunosensor is label-free and uses non-Faradaic impedance with low nonperturbing AC voltage for detection. The sensitivity of a capacitive immunosensor can be enhanced by simply tuning the ionic strength of the sample solution. The device exhibits an LOD of 0.4 BAU/ml, as determined from the standard curve using WHO IS for anti-SARS-CoV-2 immunoglobulins; this LOD is similar to the corresponding LODs reported for all validated and established commercial assays, which range from 0.41 to 4.81 BAU/ml. The proof-of-concept biosensor has been demonstrated to detect anti-spike antibodies in sera from patients infected with COVID-19 within 1 h.
dc.identifier.citation
Shoute, L. C. T., Abdelrasoul, G. N., Ma, Y., Duarte, P. A., Edwards, C., Zhuo, R., Zeng, J., Feng, Y., Charlton, C. L., Kanji, J. N., Babiuk, S., & Chen, J. (2023). Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies. Microsystems & Nanoengineering, 9, Article 3. https://doi.org/10.1038/s41378-022-00460-5
dc.identifier.doi
https://doi.org/10.1038/s41378-022-00460-5
dc.identifier.issn
2055-7434
dc.identifier.uri
https://open-science.canada.ca/handle/123456789/2844
dc.language.iso
en
dc.publisher
Springer Nature
dc.rights - en
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.rights - fr
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.rights.openaccesslevel - en
Gold
dc.rights.openaccesslevel - fr
Or
dc.rights.uri - en
https://creativecommons.org/licenses/by/4.0/
dc.rights.uri - fr
https://creativecommons.org/licenses/by/4.0/deed.fr
dc.subject - en
Health and safety
Science and technology
dc.subject - fr
Santé et sécurité
Sciences et technologie
dc.subject.en - en
Health and safety
Science and technology
dc.subject.fr - fr
Santé et sécurité
Sciences et technologie
dc.title - en
Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies
dc.type - en
Article
dc.type - fr
Article
local.acceptedmanuscript.articlenum
3
local.article.journaltitle
Microsystems & Nanoengineering
local.article.journalvolume
9
local.pagination
1-16
local.peerreview - en
Yes
local.peerreview - fr
Oui
local.requestdoi
No
Download(s)

Original bundle

Now showing 1 - 1 of 1

Thumbnail image

Name: LabelFreeImpedimetricImmunosensorForPointOfCareDetectionOfCOVID-19Antibodies_2023.pdf

Size: 1.21 MB

Format: PDF

Download file

Collection(s)

Page details

Date modified: